TISAGENLECLEUCEL for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 494 adverse event reports in the FDA FAERS database where TISAGENLECLEUCEL was used for Product used for unknown indication.
Most Reported Side Effects for TISAGENLECLEUCEL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 1,660 | 39.3% | 505 | 696 |
| Pyrexia | 1,030 | 24.4% | 311 | 427 |
| Malignant neoplasm progression | 582 | 13.8% | 400 | 126 |
| Hypotension | 425 | 10.1% | 156 | 214 |
| Immune effector cell-associated neurotoxicity syndrome | 416 | 9.8% | 127 | 183 |
| Neurotoxicity | 411 | 9.7% | 146 | 155 |
| Platelet count decreased | 397 | 9.4% | 182 | 77 |
| White blood cell count decreased | 392 | 9.3% | 164 | 59 |
| Hypogammaglobulinaemia | 374 | 8.8% | 126 | 38 |
| Lymphocyte count decreased | 365 | 8.6% | 139 | 38 |
| Acute lymphocytic leukaemia recurrent | 361 | 8.5% | 100 | 71 |
| Neutrophil count decreased | 358 | 8.5% | 134 | 58 |
| Haemoglobin decreased | 356 | 8.4% | 175 | 47 |
| Diffuse large b-cell lymphoma | 300 | 7.1% | 229 | 69 |
| Death | 282 | 6.7% | 282 | 30 |
Other Indications for TISAGENLECLEUCEL
Diffuse large b-cell lymphoma (1,321)
Acute lymphocytic leukaemia (928)
B-cell type acute leukaemia (354)
Acute lymphocytic leukaemia recurrent (225)
Diffuse large b-cell lymphoma recurrent (118)
B-cell lymphoma (87)
Non-hodgkin's lymphoma (86)
Follicular lymphoma (82)
Diffuse large b-cell lymphoma refractory (72)
Lymphoma (61)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)